CRWM
PFE icon

Castle Rock Wealth Management’s Pfizer PFE Stock Holding History

Castle Rock Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Sell
14,593
-406
-3% -$10.6K 0.07% 207
2026
Q1 		$425K Buy
14,999
+482
+3% +$12.8K 0.09% 174
2025
Q4 		$373K Sell
14,517
-1,335
-8% -$33.7K 0.08% 189
2025
Q3 		$426K Buy
15,852
+2,632
+20% +$65K 0.09% 172
2025
Q2 		$323K Buy
+13,220
New +$308K 0.08% 200
2024
Q4 		– Sell
-6,881
Closed -$203K – 256
2024
Q3 		$203K Sell
6,881
-5,517
-44% -$161K 0.05% 240
2024
Q2 		$350K Buy
12,398
+1,423
+13% +$39.2K 0.09% 180
2024
Q1 		$298K Sell
10,975
-18,528
-63% -$514K 0.08% 191
2023
Q4 		$863K Buy
29,503
+1,327
+5% +$40.1K 0.26% 108
2023
Q3 		$935K Buy
28,176
+3,406
+14% +$120K 0.31% 79
2023
Q2 		$903K Buy
24,770
+17,040
+220% +$663K 0.31% 71
2023
Q1 		$297K Buy
7,730
+1,728
+29% +$74.6K 0.11% 168
2022
Q4 		$266K Buy
+6,002
New +$288K 0.12% 182
2022
Q3 		– Sell
-4,701
Closed -$251K – 213
2022
Q2 		$251K Buy
4,701
+10
+0.2% +$510 0.13% 172
2022
Q1 		$235K Sell
4,691
-728
-13% -$37.8K 0.11% 205
2021
Q4 		$286K Buy
5,419
+9
+0.2% +$446 0.12% 202
2021
Q3 		$261K Sell
5,410
-346
-6% -$15.3K 0.09% 223
2021
Q2 		$277K Buy
5,756
+212
+4% +$8.24K 0.1% 209
2021
Q1 		$214K Buy
+5,544
New +$197K 0.09% 235
2018
Q1 		– Sell
-6,629
Closed -$228K – 112
2017
Q4 		$228K Buy
+6,629
New +$226K 0.44% 86

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Castle Rock Wealth Management's PFE Position: Q2 2026 in Review

Castle Rock Wealth Management reduced its Pfizer (PFE) stake by 2.7% in Q2 2026, selling an estimated $10.6K and leaving 14,593 shares worth $348K. The position accounts for 0.07% of the portfolio, ranked #207.

Castle Rock Wealth Management first reported a position in PFE in Q4 2017 and has held it in 20 quarters since. The position peaked at $935K in Q3 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Castle Rock Wealth Management held 14,593 shares of Pfizer worth $348K as of Q2 2026.
  • Castle Rock Wealth Management sold 406 Pfizer shares in Q2 2026, an estimated $10.6K.
  • Pfizer made up 0.07% of Castle Rock Wealth Management's portfolio in Q2 2026, its #207 holding.
  • Castle Rock Wealth Management first reported a position in Pfizer in Q4 2017 and has held it in 20 quarters since.
  • Castle Rock Wealth Management's Pfizer position peaked at $935K in Q3 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Castle Rock Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.